Immunovant (IMVT) Stock Price, Quote, News & History | Benzinga

Immunovant Inc (IMVT) Stock Price, Quote, News & History

IMVTNASDAQ

Trade with Public

Trade with Public

$33.62

0.742.25%

At close: Jun 12, 5:00 PM EST

$33.62

N/A

After Hours: Jun 12, 4:00 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$32.91

Close

$33.62

Volume / Avg.

1.14M / 1.82M

Day Range

$32.62 - $33.96

52 Wk Range

14.32 - 36.28

Market Cap

$6.90B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

21.16%

Days to Cover

4.99

Recent Immunovant Inc News

These Analysts Increase Their Forecasts On Immunovant After Q4 Results

Immunovant (NASDAQ:IMVT) reported a Q4 loss of 73 cents/share, missing estimates of 60 cents. R&D expenses rose to $142.3 million. Analysts adjust price targets.

Avi Kapoor

Immunovant Stock Surges Despite Disappointing Earnings Miss

Immunovant Inc (NASDAQ: IMVT) shares are trading higher Wednesday despite posting a wider-than-expected fourth‑quarter loss.

Evette Mitkov

Roivant Signals Major Pipeline Momentum With Accelerated Timelines

Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-407.31M

Investing Cash Flow (TTM)

-8.00K

Financing Cash Flow (TTM)

595.76M

Free Cash Flow (TTM)

-407.32M

Capital Expenditure (TTM)

-8.00K

Net Change in Cash (TTM)

188.44M

Analyst Trends and Forecast

1

Dec 25

1

Jan

2

Feb

1

Apr

3

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.00B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

7.92

Earnings Yield % (TTM)

-8.42%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.15

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$902.11M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$32.91

Close

$33.62

Volume / Avg.

1.14M / 1.82M

Day Range

$32.62 - $33.96

52 Wk Range

14.32 - 36.28

Market Cap

$6.90B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

21.16%

Days to Cover

4.99

About

Sector

Health Care

Industry

Biotechnology

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to addr...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Immunovant (IMVT) stock?

A

You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Immunovant (IMVT) competitors?

A

There are no as such competitors for Immunovant.

Q

What is the forecast, or price target, for Immunovant (IMVT) stock?

A

Immunovant has a consensus price target of $41.06.

Q

What is the current price for Immunovant (IMVT)?

A

The stock price for Immunovant (NASDAQ: IMVT) is $33.62 last updated June 12, 2026 at 4:00 PM EDT.

Q

Does Immunovant (IMVT) pay a dividend?

A

There are no upcoming dividends for Immunovant.

Q

When is Immunovant (NASDAQ:IMVT) reporting earnings?

A

Immunovant does not have any upcoming earnings scheduled.

Q

Is Immunovant (IMVT) going to split?

A

There is no upcoming split for Immunovant.

Q

What sector and industry does Immunovant (IMVT) operate in?

A

Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.